|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.65 TWD | -0.24% |
|
-1.20% | -18.38% |
| 15/04 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
| 21/03 | Applied BioCode Announces CEO Changes | CI |
Applied BioCode Corporation announced the Change of Sales Director. Date of occurrence of the change is August 25, 2022. Name, title, and resume of the previous position holder: Michael Jason Scott/Sales Director.
Name, title, and resume of the new position holder: Craig Griz Adams/Sales Director. Reason for the change: New replacement. Effective date is August 25, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.38% | 5.26Cr | |
| -36.40% | 919.7Cr | |
| -3.33% | 312.29Cr | |
| +20.11% | 280.11Cr | |
| -18.71% | 206.79Cr | |
| -22.03% | 159.01Cr | |
| +65.57% | 144.12Cr | |
| +33.08% | 83Cr | |
| -7.42% | 72Cr | |
| -25.82% | 51Cr |
APPLIED BIOCODE CORPORATION 
